Incorporating the Central Vein Sign Into the Diagnostic Criteria for Multiple Sclerosis
Authors:
- 1 July 2023
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 80 (7) , 657-658
Abstract
This Viewpoint discusses incorporating the central vein sign into the diagnostic criteria for multiple sclerosis.Keywords
This publication has 10 references indexed in Scilit:
- Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple SclerosisAmerican Journal of Roentgenology, 2023
- Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trialNeuroImage: Clinical, 2021
- The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysisDiagnostics, 2020
- Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple SclerosisJAMA Neurology, 2019
- Incidence of multiple sclerosis misdiagnosis in referrals to two academic centersMultiple Sclerosis and Related Disorders, 2019
- Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated SyndromeJAMA Neurology, 2018
- Automated Integration of Multimodal MRI for the Probabilistic Detection of the Central Vein Sign in White Matter LesionsAmerican Journal of Neuroradiology, 2018
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaThe Lancet Neurology, 2018
- The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis CooperativeNature Reviews Neurology, 2016
- Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosisMultiple Sclerosis Journal, 2014